Skip to main content
. 2019 Nov 18;27(2):721–733. doi: 10.1007/s40199-019-00309-9

Table 2.

Effect of EA on MTX-induced liver histological changes. EA, Ellagic acid; MTX, methotrexate

Groups Histological score Degenerative changes
Control 1 No abnormality
MTX 5 Extensive pathologic changes such as prominent granular degeneration, inflammation, eosinophilic cells, vacuolation etc.
MTX + EA 5 mg/kg 3 Moderate pathologic changes such as Inflammation
MTX + EA 10 mg/kg 2 Mild pathological changes

1: No abnormality 2: Mild degenerative changes (10%). 3: Moderate degenerative changes (25%). 4: Severe degenerative changes (50%). 5: Extensive and marked changes (>75%)